R484Q (p.Arg484Gln) variant of ACVRL1 (Activin receptor type-1-like)
R484Q (p.Arg484Gln) in ACVRL1 (Activin receptor type-1-like) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic in the context of Epistaxis; Pulmonary arterial hypertension; not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.86 / 1. The record also includes published literature and structural context.
R484Q (p.Arg484Gln) variant details
- p.Arg484Gln
- rs863223408
- ClinGen CA323134
- NCI-TCGA Cosmic COSV1011
- cosmic curated COSV10118
- Pathogenic
- Epistaxis; Pulmonary arterial hypertension; not provided
- Missense
- Variant Prioritization Score for Impact Estimate 0.859
- AlphaMissense 0.88
- MetaLR 0.80
- MetaSVM 0.79
- PolyPhen-2 1.00
- SIFT 0.00
- MutPred 0.91
- ClinVar: Pathogenic (Epistaxis; Pulmonary arterial hypertension; not provided)
- EBI: Pathogenic (in HHT2)
- UniProt: Pathogenic (in HHT2)
- Structural context available
- Cited in: Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). (PMID 10751092)
- Cited in: International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. (PMID 19553198)